Search research articles
Contact Us
Filters
Showing results (161-170 of 460) with videos related to
Page
of 46
Sort By:
Health and Quality of Life Outcomes
|
May 14, 2013
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
Vibeke Strand, David Fiorentino, ChiaChi Hu, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 1987
High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine
R H Barbhaiya, S T Forgue, W C Shyu, et al.
Dermatology and Therapy
|
January 29, 2021
Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial
Kim A Papp, Saskia de Vente, Jiewei Zeng, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis
Melinda J Gooderham, Robert Bissonnette, Parbeer Grewal, et al.
Journal of Drugs in Dermatology : JDD
|
March 17, 2017
Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2
Kristina C Duffin, Kim A Papp, Jerry Bagel, et al.
Acta Biologica Hungarica
|
November 9, 2012
Repeated simultaneous cortical electrophysiological and behavioral recording in rats exposed to manganese-containing nanoparticles
S Z Takács, Andrea Szabó, G Oszlánczi, et al.
Pediatrics
|
December 20, 2005
Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years
Carle Paul, Michael Cork, Ana B Rossi, et al.
Biochimica Et Biophysica Acta
|
June 12, 1987
Interactions of polymerizable phosphatidylcholine vesicles with blood components: relevance to biocompatibility
F Bonté, M J Hsu, A Papp, et al.
International Journal of Dermatology
|
December 15, 2010
A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis
Yves Poulin, Kim A Papp, Norman R Wasel, et al.
Psychiatry Research
|
September 27, 1996
Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report
J M Kent, J D Coplan, J Martinez, et al.
Page
of 46
Search research articles
Search
Showing results (161-170 of 460) with videos related to
Sort By:
Page
of 46
Health and Quality of Life Outcomes
|
May 14, 2013
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
Vibeke Strand, David Fiorentino, ChiaChi Hu, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 1987
High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine
R H Barbhaiya, S T Forgue, W C Shyu, et al.
Dermatology and Therapy
|
January 29, 2021
Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial
Kim A Papp, Saskia de Vente, Jiewei Zeng, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis
Melinda J Gooderham, Robert Bissonnette, Parbeer Grewal, et al.
Journal of Drugs in Dermatology : JDD
|
March 17, 2017
Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2
Kristina C Duffin, Kim A Papp, Jerry Bagel, et al.
Acta Biologica Hungarica
|
November 9, 2012
Repeated simultaneous cortical electrophysiological and behavioral recording in rats exposed to manganese-containing nanoparticles
S Z Takács, Andrea Szabó, G Oszlánczi, et al.
Pediatrics
|
December 20, 2005
Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years
Carle Paul, Michael Cork, Ana B Rossi, et al.
Biochimica Et Biophysica Acta
|
June 12, 1987
Interactions of polymerizable phosphatidylcholine vesicles with blood components: relevance to biocompatibility
F Bonté, M J Hsu, A Papp, et al.
International Journal of Dermatology
|
December 15, 2010
A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis
Yves Poulin, Kim A Papp, Norman R Wasel, et al.
Psychiatry Research
|
September 27, 1996
Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report
J M Kent, J D Coplan, J Martinez, et al.
Page
of 46